Literature DB >> 15662524

The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background.

Hui-Chuan Sun1, Zhao-You Tang, Zeng-Chen Ma, Lun-Xiu Qin, Lu Wang, Qin-Hai Ye, Jia Fan, Zhi-Quan Wu, Xin-Da Zhou.   

Abstract

PURPOSE: Second resection has been proved to be a safe and effective treatment for patients with intrahepatic recurrent HCC after primary resection; however, preoperative prognostic factors for outcome following second resection in patients with a hepatitis B virus (HBV) infection background remains to be clarified.
METHODS: Fifty-seven patients with intrahepatic recurrent an HCC and HBV infection background received second resection from 1997 to 2003 in our institute. All of them were negative for anti-hepatitis C virus (HCV) and positive regarding HBV profile. Patient and tumor factors were analyzed.
RESULTS: At the time of preparing this paper, 31 had re-recurrence and 21 patients had died. No postoperative mortality was noted. The 1-, 3-, and 5-year overall survival after second resection were 69.9%, 61.2%, and 30.6%, respectively. Univariate and multivariate analysis showed that vascular invasion and time to recurrence were the independent prognostic factors for overall survival following second resection. The 3- and 4-year overall survival after second resection were 57.7% and 46.6% in patients with the presence of any of two risk factors (n = 46), and 100% and 100% in those with absence of both risk factors (n = 11, P = 0.008).
CONCLUSIONS: Vascular invasion and time to recurrence were the prognostic factors for overall survival following second resection of intrahepatic recurrent HCC.

Entities:  

Mesh:

Year:  2005        PMID: 15662524     DOI: 10.1007/s00432-004-0645-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  35 in total

1.  Repeat hepatectomy for recurrent hepatocellular carcinoma.

Authors:  N Nagasue; H Kohno; T Hayashi; M Uchida; T Ono; H Yukaya; A Yamanoi
Journal:  Br J Surg       Date:  1996-01       Impact factor: 6.939

2.  Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial.

Authors:  E C Lai; C M Lo; S T Fan; C L Liu; J Wong
Journal:  Arch Surg       Date:  1998-02

3.  Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma.

Authors:  K Sugimachi; S Maehara; S Tanaka; M Shimada; K Sugimachi
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

4.  Treatment of recurrent hepatocellular carcinoma by radiofrequency thermal ablation.

Authors:  N Nicoli; A Casaril; L Marchiori; G Mangiante; A R Hasheminia
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

5.  Surgery of small hepatocellular carcinoma. Analysis of 144 cases.

Authors:  Z Y Tang; Y Q Yu; X D Zhou; Z C Ma; R Yang; J Z Lu; Z Y Lin; B H Yang
Journal:  Cancer       Date:  1989-07-15       Impact factor: 6.860

6.  Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation.

Authors:  Albana Gattelli; María Cecilia Cirio; Ana Quaglino; Carolina Schere-Levy; Natalia Martinez; María Binaghi; Roberto P Meiss; Lucio H Castilla; Edith C Kordon
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

7.  Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization.

Authors:  H Ishii; S Okada; T Sato; H Nose; T Okusaka; M Yoshimori; K Takayasu; T Takayama; T Kosuge; S Yamasaki
Journal:  Hepatogastroenterology       Date:  1996 May-Jun

Review 8.  Progress and prospects in hepatocellular carcinoma surgery.

Authors:  Z Y Tang; Y Q Yu; X D Zhou; Z C Ma; Z Q Wu
Journal:  Ann Chir       Date:  1998

9.  Predictors and patterns of recurrence after resection of hepatocellular carcinoma.

Authors:  Charles Cha; Yuman Fong; William R Jarnagin; Leslie H Blumgart; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2003-11       Impact factor: 6.113

10.  Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.

Authors:  Lawrence E Harrison; Baburao Koneru; Phil Baramipour; Adrian Fisher; Alison Barone; Dorian Wilson; Andrew Dela Torre; Kyunghee C Cho; Daniel Contractor; Maria Korogodsky
Journal:  J Am Coll Surg       Date:  2003-11       Impact factor: 6.113

View more
  4 in total

Review 1.  Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review.

Authors:  Yanming Zhou; Chengjun Sui; Bin Li; Zhengfeng Yin; Yunchang Tan; Jiamei Yang; Zhenyu Liu
Journal:  World J Surg Oncol       Date:  2010-07-01       Impact factor: 2.754

2.  Is the anatomical resection necessary for single hepatocellular carcinoma smaller than 3 cm?: single-center experience of liver resection for a small HCC.

Authors:  Sungwook Shin; Tae-Seok Kim; Jeong Woo Lee; Keun Soo Ahn; Yong Hoon Kim; Koo Jeong Kang
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-11-27

3.  Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation.

Authors:  Hui Ma; Zhongchen Li; Jia Yuan; Lan Zhang; Xiaoying Xie; Xin Yin; Rongxin Chen; Zhenggang Ren
Journal:  Gastroenterol Res Pract       Date:  2021-01-02       Impact factor: 2.260

Review 4.  Liver-Directed Treatment Options Following Liver Tumor Recurrence: A Review of the Literature.

Authors:  Christopher T Aquina; Mariam F Eskander; Timothy M Pawlik
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.